UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000039800
Receipt number R000045391
Scientific Title Development of risk indicators for vascular diseases with multi-omics and non-invasive blood flow analysis
Date of disclosure of the study information 2020/05/01
Last modified on 2020/03/12 23:11:55

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Development of risk indicators for vascular diseases with multi-omics and non-invasive blood flow analysis

Acronym

Development of risk indicators for vascular diseases with multi-omics and non-invasive blood flow analysis

Scientific Title

Development of risk indicators for vascular diseases with multi-omics and non-invasive blood flow analysis

Scientific Title:Acronym

Development of risk indicators for vascular diseases with multi-omics and non-invasive blood flow analysis

Region

Japan


Condition

Condition

1.Diabetes and its complications
2.Vascular diseases

Classification by specialty

Medicine in general Cardiology Endocrinology and Metabolism
Nephrology Ophthalmology

Classification by malignancy

Others

Genomic information

YES


Objectives

Narrative objectives1

To develop risk indicators related to the onset, severity and prognosis of diabetic complications and various vascular diseases

Basic objectives2

Others

Basic objectives -Others

To develop an artificial intelligence algorithm to predict the risk of various vascular diseases

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Factors associated with the development and progression of various vascular diseases

Key secondary outcomes

1.Factors associated with the presence, disease subtype, severity, and treatment response of various vascular diseases
2.Factors associated with ocular blood flow
3.Factors associated with the levels of HbA1c
4.Factors associated with nail bed capillaries
5.Factors associated with the degree of oxidative stress


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. Diabetes and its complications
2. Fundus diseases other than diabetic retinopathy
3. Uveitis
4. Lifestyle-related diseases other than diabetes and obesity without diabetes
5. Cardio-cerebrovascular disease
6. Cataract, epiretinal membrane, macular hole, hypertension, dyslipidemia without the above diseases

Key exclusion criteria

Patients who disagreed with participating this study.

Target sample size

7000


Research contact person

Name of lead principal investigator

1st name Toru
Middle name
Last name Nakazawa

Organization

Tohoku University Graduate School of Medicine

Division name

Department of Ophthalmology

Zip code

980-8574

Address

Seiryo-cho Aoba-ku Sendai-shi Miyagi-ken

TEL

022-717-7294

Email

ntoru@oph.med.tohoku.ac.jp


Public contact

Name of contact person

1st name Masayuki
Middle name
Last name Yasuda

Organization

Tohoku University Hospital

Division name

Department of Ophthalmology

Zip code

980-8574

Address

Seiryo-cho Aoba-ku Sendai-shi Miyagi-ken

TEL

022-717-7294

Homepage URL


Email

myasuda@oph.med.tohoku.ac.jp


Sponsor or person

Institute

Tohoku University

Institute

Department

Personal name



Funding Source

Organization

Tohoku University

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethics Committee Tohoku University Graduate School of Medicine

Address

2-1, Seiryo-cho, Aoba-ku, Sendai-shi, Miyagi-ken

Tel

022-717-8007

Email

med-kenkyo@grp.tohoku.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 05 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2020 Year 04 Month 20 Day

Date of IRB


Anticipated trial start date

2020 Year 04 Month 21 Day

Last follow-up date

2030 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

We aim to identify biomarkers of vascular diseases in various organs throughout the body, mainly for diabetic complications. We will analyze biosamples and non-invasive vascular imaging data for this purpose.


Management information

Registered date

2020 Year 03 Month 12 Day

Last modified on

2020 Year 03 Month 12 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045391


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name